期刊
CLINICAL RHEUMATOLOGY
卷 31, 期 1, 页码 13-21出版社
SPRINGER LONDON LTD
DOI: 10.1007/s10067-011-1877-0
关键词
Chronic diseases; Gouty arthritis; Inflammation; Pathophysiology
类别
资金
- Novartis Pharmaceuticals Corporation
Gouty arthritis is an inflammatory condition associated with debilitating clinical symptoms, functional impairments, and a substantial impact on quality of life. This condition is initially triggered by the deposition of monosodium urate crystals into the joint space. This causes an inflammatory cascade resulting in the secretion of several proinflammatory cytokines and neutrophil recruitment into the joint. While generally effective, currently available agents are associated with a number of adverse events and contraindications that complicate their use. Based on our increased understanding of the inflammatory pathogenesis of gouty arthritis, several new agents are under development that may provide increased efficacy and reduced toxicity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据